More on ‘independent’ patient groups

Some more investigation from Bob Fiddaman at Seroxat Sufferers, this time involving Glaxo and its Asthma drug Seretide, in Australia. See the whole post here.

Meet Puff the purple dragon. Last year Puff became the public face of a new National Asthma Council awareness campaign to encourage asthmatics to better manage their medications.

But Puff had an earlier existence. He began life as the registered trademark used by international pharmaceutical giant GlaxoSmithKline to market one of its asthma drugs, Seretide, to doctors. His colour matches the packaging for Seretide.

It was GlaxoSmithKline’s idea for the NAC to use its symbol and give Puff a new, much more public role encouraging asthmatics to update their medication regimens.

GlaxoSmithKline, which is the world’s biggest seller of asthma medications, also provided financial support for the television campaign and to develop an interactive internet quiz for the NAC website to check whether someone’s asthma was under control. Even if you answer “no” to the initial question “do you have asthma?” and say you have no symptoms, Puff advises you that your asthma appears to be under control, but you should visit your doctor anyway for a medical review.

No conflicts of interest here, then…


One Response to “More on ‘independent’ patient groups”

  1. seroxat secrets… Top posts for May « Says:

    […] More on ‘independent’ patient groups […]

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: